Navigation Links
Advanced Health Media Announces Acquisition of Ephikacy, LLC
Date:10/8/2009

will allow Ephikacy to expand its client base as well as provide additional resources for its existing customers. Ephikacy, LLC will continue to operate from its Chicago, IL offices, thus expanding AHM's footprint in the mid-west.

About Advanced Health Media, LLC

Advanced Health Media (AHM) is the leading U.S. provider of speaker-led meeting logistics, state and federal regulatory compliance technology, thought leader development and medical communications. AHM has developed and markets a fully integrated suite of hosted technology solutions and sales support services designed to address the diverse operational and compliance management needs of its clients, including corporate speaker bureau and event management solutions, sales force automation technology, customer relationship management, and compliance tracking and reporting systems. AHM also provides full-service medical communications, including strategic communication strategy, publication planning, scientific meetings and key opinion leader advocacy development. AHM provides services to more than 50 companies in the pharmaceutical sector.

Headquartered in Bridgewater, N.J., with offices in Union and Somerville, N.J., Chesapeake, Virginia, and Chicago, Illinois, AHM is the parent company of AHM Solutions, Centeon Solutions, Embryon, LLC, Cogenix, LLC, ProMedix, LLC, and InsiteResearch, LLC. For more information, please visit the AHM Web site at www.ahmdirect.com.

About Ephikacy, LLC

Ephikacy, LLC is a provider of marketing and communication solutions for the healthcare industry. The company's innovative product and services incorporate state of the art technologies to improve communications among brand teams, speaker bureaus, healthcare professionals and sales forces. Ephikacy, LLC is located in Chicago, Illinois and works with top pharmaceutical and biotechnology companies in the United Stat
'/>"/>

SOURCE Advanced Health Media, LLC
Copyright©2009 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2 3

Related medicine technology :

1. Telik Announces Publication of Positive Phase 1-2a Results of a Multicenter Study of TELCYTA(R) in Combination With Carboplatin and Paclitaxel in Patients With Advanced Non-Small Cell Lung Cancer
2. The Most Advanced Solution for the Reduction of Stretch Marks Based on TriPollar(R) Technology Presented at the Upcoming EADV Congress
3. OPAXIO Produces High Rates of Pathologic Complete Remission in Patients with Advanced Esophageal Cancer; Study Paves Way for Potential Registration Trial as Radiation Sensitizer
4. Medivation Announces Initiation of Phase 3 Clinical Trial of MDV3100 in Advanced Prostate Cancer
5. Phase 3 Trial Shows Denosumab Delayed Skeletal Related Events in Advanced Cancer Patients With Bone Metastases
6. Keryx Biopharmaceuticals Phase 2 Data of KRX-0401 (Perifosine) in the Treatment of Advanced Metastatic Renal Cell Cancer Selected for Oral Presentation at the Eighth International Kidney Cancer Symposium
7. Medigus and Tower Semiconductor Announce Worlds Smallest Medical Video Camera Based on Advanced CMOS Image Sensor
8. OPAXIO(TM) Combined with Alimta(R) Well Tolerated in Dose-Ranging Study of Patients with Advanced Non-Small Cell Lung Cancer
9. CuraGen Announces Expansion of CR011-vcMMAE Phase II Trial in Advanced Breast Cancer
10. Advanced Life Sciences Announces Outcome of FDAs Anti-Infective Drugs Advisory Committee Review of Restanza(TM) (cethromycin)
11. PharmAthene Submits Proposal to BARDA in Response to Broad Agency Announcement for Advanced Research and Development for Valortim(R)

Post Your Comments:
*Name:
*Comment:
*Email:
(Date:11/19/2009)...9 /PRNewswire-Asia/ -- ScinoPharm, a leading globa...PIs), announced that its,Tainan facility has recei...SafeBridge(R) Consultants, Inc. The Certification ...n the safe handling of potent active,pharmaceutica...ratories and,production areas used for the manufac...
(Date:11/19/2009)...wire/ -- Riverain Medical announced today that the...medical imaging distributor Christie Group to offe...t Xray CAD. The exclusive agreement will bring Day... Canadian market through Christie Group,s establis...hanced Chest Imaging increases the clarity of digi...
(Date:11/19/2009)... Ligon Discovery, Inc., which uses ...o find drugs against high-value targets, today ann...d by incTANK Ventures. The company will use the ca...hat will screen over 100 high-value disease protei...General Partner Christian Bailey joins the board. ...
Breaking Medicine Technology:ScinoPharm Announces SafeBridge Potent Compound Safety Certification 2Riverain Medical Partners With The Christie Group In Canada To Offer SoftView Enhanced Chest Imaging and OnGuard Chest X-Ray CAD Technologies 2Cambridge-based Ligon Discovery Raises $1M in Seed Funding 2Cambridge-based Ligon Discovery Raises $1M in Seed Funding 3NeoVista Inc Announces Initial VIDION Shipments 60378 1NeoVista Inc Announces Initial VIDION Shipments 60378 2NeoVista Inc Announces Initial VIDION Shipments 60378 3SCM Microsystems Announces Results of Annual Meeting 10583 1SCM Microsystems Announces Results of Annual Meeting 10583 21 disease not 1 demographic 60373 11 disease not 1 demographic 60373 21 disease not 1 demographic 60373 3
...f ,First Generation, Antisense, BERKELEY HEIGHTS,...) announced the presentation of new data showing,t...s lead anticancer,compound, can be safely administ...usion. The new data were presented by Dr. Anthony ...s Accelerated Research Therapeutics,(START), and C...
...g Application for TREANDA by End of ...phalon, Inc. (Nasdaq:,CEPH) today announced positi...A(R) (bendamustine HCl) in patients with indolent ...nger responsive to treatment with,rituximab. The s... rate and,median duration of response, while demon...
Other Medicine Technology:Genasense(R) Can be Administered by Brief High-Dose IV Infusion 2Genasense(R) Can be Administered by Brief High-Dose IV Infusion 3Genasense(R) Can be Administered by Brief High-Dose IV Infusion 4Cephalon Announces Positive Results from Its Pivotal Study of TREANDA in Patients with Non-Hodgkin's Lymphoma 2Cephalon Announces Positive Results from Its Pivotal Study of TREANDA in Patients with Non-Hodgkin's Lymphoma 3Cephalon Announces Positive Results from Its Pivotal Study of TREANDA in Patients with Non-Hodgkin's Lymphoma 4
(Date:11/22/2009)...Nov. 21 Congressman Cha...on the United States Senate,s vote tonight to proc...n: ,, "Senators Arlen Specter and Bob Casey des...anians for casting stand-up, critical votes in the...ic Affordable Health Care Reform legislation to fu...
(Date:11/21/2009)...N, Nov. 21 A regional i...cerciasis (river blindness) in the Americas has su...in recent years, as evidenced by a 31% decrease in...inistration in six endemic countries. Results wer... American Society of Tropical Medicine and Hygiene...
(Date:11/21/2009)... HAPPYneuron,s most popular and addictive game,...od Touch. , Mountain View...st popular and addictive game, SplitWords, is now ...s is designed to help banish that ,tip of the tong...brain game challenges the brain by encouraging us...
(Date:11/20/2009)... NJ, Nov. 20 /PRNewswire-FirstCall/ - NUCRYST Phar...eeting of Shareholders will be held on Monday, Dec...onsider approval of two special resolutions. The f...e the sale of all or substantially all of the asse... for in the asset purchase agreement dated Novembe...
(Date:11/20/2009)... N.J., Nov. 20 Rates of ...e peaked in late October, but the pandemic flu vir...n all age groups, including the elderly, according... (NYSE: DGX ), the world,s leading provider of d..., In its most recent Quest Diagnostics Health Tren...
Breaking Medicine News(10 mins):Health News:River Blindness (Onchocerciasis) Reduced By Nearly One-Third In At-Risk Populations In Six Countries 2Health News:River Blindness (Onchocerciasis) Reduced By Nearly One-Third In At-Risk Populations In Six Countries 3Health News:River Blindness (Onchocerciasis) Reduced By Nearly One-Third In At-Risk Populations In Six Countries 4Health News:HAPPYneuron releases iPhone Brain Game 2Health News:HAPPYneuron releases iPhone Brain Game 3Health News:NUCRYST Announces Special Meeting of Shareholders 2Health News:NUCRYST Announces Special Meeting of Shareholders 3Health News:H1N1 Pandemic May Have Peaked in October in U.S., According to Quest Diagnostics 2Health News:H1N1 Pandemic May Have Peaked in October in U.S., According to Quest Diagnostics 3
...showed that slimmer people mostly commit suicide a...nd that depression level decreased as Body Mass In...t people who are overweighed felt very depressed b...ound that people who committed suicide had a lower...
...encephalitis in India’s Bihar State has taken a to...here is panic among the people of Bagaha District ... Health Minister of Bihar however seems to be unaw...brain caused by a virus. The district admini...
... American scientists has sparked new fears over th...le that they should eat no more than two portions ...lbany, part of New York State University, conclude... fed determine whether the health risks will outwe...
...Hempstead oil depot fire accident has been describ... engaged in putting out the blaze. The flames are ...ls.// Fears of a yet another explosion from a high...given. As many as 150 fire service personnel...
...cancer can be triggered by the common cold, accord... and brain tumors may be caused by relatively mino... flu. //This is all the more in the case of those ...may lead to the development of a vaccine which wil...
...n increase in demand for Palliative care for treat...rom Annual Survey of Hospitals, which has been rep...liative care is given to patients where chemothera...pid increase in demand for palliative care. Pall...
Other Medicine News:Health News:Salmon's own diet sure to affect yours 2Health News:Firefighters Continue To Battle Blaze 2
Hartman Mosquito Forceps
Halstead Curved Haemostatic Mosquito Forceps - Non-Magnetic
Wills Hospital Utility Forceps
McCullough Utility Forceps
Medicine Products: